Alzheimer's Disease and Cognitive Impairment
Alzheimer's disease is a progressive neurological disorder and the most common cause of dementia worldwide. It is characterized by the gradual loss of memory, reasoning, and cognitive function, caused by the degeneration of neurons and disruption of communication between brain cells.
About the Condition
Alzheimer's disease is a progressive neurological disorder and the most common cause of dementia worldwide. It is characterized by the gradual loss of memory, reasoning, and cognitive function, caused by the degeneration of neurons and disruption of communication between brain cells.
Common Symptoms
- Progressive memory loss and forgetfulness
- Difficulty with familiar tasks and problem-solving
- Confusion about time and place
- Changes in mood, personality, or judgment
- Language and communication difficulties
Specialist Assessment
A comprehensive neurological and clinical evaluation conducted by CIREN specialists. This includes neurological and neuropsychological examinations, psychomotor evaluation (LEIS), neuroimaging (MRI, cerebral SPECT), neurophysiology studies, and clinical laboratory tests to define the precise neurological profile and confirm therapeutic possibilities.
Rehabilitation Approaches
Intensive, personalized, multidisciplinary neuro-rehabilitation designed in 4-week cycles under the direction of the neurologist in charge of the case. Cognitive rehabilitation, psychological support, and functional therapy aim to support quality of life and daily functioning.
CIREN Treatment Approaches
Movement Disorders and Neurodegenerations Clinic
NeuralCIM® (NeuroEPO-plus) Therapy
A neuroprotective therapy developed in Cuba, derived from a modified form of erythropoietin and administered intranasally. It aims to protect neurons, reduce neuroinflammation, support neuronal survival, and stabilize cognitive function in mild-to-moderate Alzheimer's disease.
Intensive Neuro-Rehabilitation
Personalized, multidisciplinary rehabilitation combining cognitive therapy, physiotherapy, and occupational therapy, delivered intensively in 4-week cycles under the direction of the neurologist.
Comprehensive Neurological Evaluation
Up to 7 days of diagnosis and evaluation, including neuropsychological testing, neuroimaging (MRI, SPECT), neurophysiology, and laboratory tests to design the individualized treatment program.
Pharmacological Management
Advanced drug strategies for motor and non-motor symptoms, using the most current medications worldwide as part of the multifactorial treatment strategy.
Limitations of Treatment
There is currently no cure for Alzheimer's disease. Rehabilitation and neuroprotective therapy aim to stabilize progression and support cognitive function, not to reverse the disease. Treatment outcomes vary by individual and are confirmed only after specialist evaluation.
Medication-based treatment is separate from rehabilitation services. NeuralCIM® may be relevant to this condition where supported by reliable, indication-specific evidence — see the NeuralCIM® section for details.
Ready to learn more?
Contact the International Patient Coordination Desk for assistance.